{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T21:51:48Z","timestamp":1762638708910,"version":"build-2065373602"},"reference-count":61,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007861","name":"University of Gondar","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020570","name":"College of Medicine, Nursing and Health Sciences, University of Galway","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020570","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["heartrhythmopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm O2"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.hroo.2025.06.016","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T07:09:21Z","timestamp":1751008161000},"page":"1435-1447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of physicians\u2019 adherence to guideline-directed medical therapy among patients with heart failure with reduced ejection fraction at the University of Gondar Comprehensive Specialized Hospital, Northwest, Ethiopia, 2023"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2945-0306","authenticated-orcid":false,"given":"Sisay Sitotaw","family":"Anberbr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ousman Abubeker","family":"Abdela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alemneh Ayu","family":"Biyazin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gebremariam Wulie","family":"Geremew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adane Desta","family":"Getahun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Getachew Yitayew","family":"Tarekegn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agegnehu Derbew","family":"Teshager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masho Tigabe","family":"Tekle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hroo.2025.06.016_bib1","first-page":"e895","article-title":"AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2025.06.016_bib2","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hroo.2025.06.016_bib3","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"James","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.hroo.2025.06.016_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3390\/healthcare10010107","article-title":"Burden of chronic heart failure in Romania","volume":"10","author":"Lorenzovici","year":"2022","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.hroo.2025.06.016_bib5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11897-013-0155-7","article-title":"The emerging epidemic of heart failure with preserved ejection fraction","volume":"10","author":"Oktay","year":"2013","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.hroo.2025.06.016_bib6","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/ejhf.935","article-title":"JoHF. How have millions of people with heart failure benefited from our research over the last 10\u201315 years? The sounds of dead silence","volume":"19","author":"Packer","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hroo.2025.06.016_bib7","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hroo.2025.06.016_bib8","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1172\/JCI24351","article-title":"Genetic causes of human heart failure","volume":"115","author":"Morita","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hroo.2025.06.016_bib9","first-page":"9","article-title":"Spectrum of cardiovascular diseases among Ethiopian patients at Tikur Anbessa Specialized University Teaching Hospital, Addis Ababa","volume":"52","author":"Abdissa","year":"2014","journal-title":"Ethiop Med J"},{"key":"10.1016\/j.hroo.2025.06.016_bib10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ijcard.2017.12.048","article-title":"Heart failure in sub-Saharan Africa: a contemporaneous systematic review and meta-analysis","volume":"257","author":"Agbor","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hroo.2025.06.016_bib11","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.dib.2018.01.100","article-title":"Data on the epidemiology of heart failure in sub-Saharan Africa","volume":"17","author":"Nyaga","year":"2018","journal-title":"Data Brief"},{"key":"10.1016\/j.hroo.2025.06.016_bib12","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jcma.2017.04.011","article-title":"The gap between guidelines and clinical practice in heart failure with reduced ejection fraction: results from TSOC-HFrEF registry","volume":"80","author":"Chang","year":"2017","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.hroo.2025.06.016_bib13","doi-asserted-by":"crossref","unstructured":"Nilufar F, Sharma R, Poole Wilson P, Galloway C. Evidence-based optimization of medical therapy in chronic heart failure. 2009;5:32\u201335.","DOI":"10.3329\/uhj.v5i1.3439"},{"key":"10.1016\/j.hroo.2025.06.016_bib14","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jacc.2020.11.022","volume":"77","author":"Maddox","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2025.06.016_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003529","article-title":"Thirty years of evidence on the efficacy of drug treatments for chronic heart failure with reduced ejection fraction: a network meta-analysis","volume":"10","author":"Burnett","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hroo.2025.06.016_bib16","first-page":"355","article-title":"Optimization of heart failure medical Treatment after hospital discharge according to left ventricular ejection fraction","volume":"105","author":"Solal","year":"2012","journal-title":"Future Surv"},{"key":"10.1016\/j.hroo.2025.06.016_bib17","first-page":"101","article-title":"The use of beta-blockers in heart failure with reduced ejection fraction","volume":"8","author":"Masarone","year":"2021","journal-title":"J Cardiovasc Dev Dis"},{"issue":"7","key":"10.1016\/j.hroo.2025.06.016_bib18","article-title":"The gap to fill: rationale for rapid initiation and optimal titration of comprehensive disease-modifying medical therapy for heart failure with reduced ejection fraction","volume":"26","author":"Brownell","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.hroo.2025.06.016_bib19","doi-asserted-by":"crossref","unstructured":"Verhestraeten C, Heggermont WA, Maris MJHFR. Clinical inertia in the treatment of heart failure: a major issue to tackle 2021;26:1359\u20131370.","DOI":"10.1007\/s10741-020-09979-z"},{"key":"10.1016\/j.hroo.2025.06.016_bib20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","article-title":"Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry","volume":"72","author":"Greene","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2025.06.016_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcha.2018.10.003","article-title":"Evaluation of a guideline-directed medical therapy titration program in patients with heart failure with reduced ejection fraction","volume":"22","author":"Balakumaran","year":"2019","journal-title":"IJC Heart Vasc"},{"key":"10.1016\/j.hroo.2025.06.016_bib22","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/ehf2.13929","article-title":"Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction","volume":"9","author":"Girerd","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.hroo.2025.06.016_bib23","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ejhf.510","article-title":"Physicians\u2019 adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey","volume":"18","author":"Komajda","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hroo.2025.06.016_bib24","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.cardfail.2018.07.382","article-title":"Reasons for failure to optimize guideline-directed medical therapy for heart failure with reduced ejection fraction patients in clinical practice","volume":"24","author":"Smith","year":"2018","journal-title":"J Card Fail"},{"key":"10.1016\/j.hroo.2025.06.016_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10741-021-10077-x","article-title":"Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction","volume":"27","author":"Greene","year":"2022","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.hroo.2025.06.016_bib26","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ejhf.1459","article-title":"Physicians\u2019 guideline adherence is associated with long-term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry","volume":"21","author":"Komajda","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hroo.2025.06.016_bib27","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/pds.4868","article-title":"Adherence to ESC guideline-recommended medications over a 36-month follow-up period after hospitalization for heart failure: results from the EPICAL2 cohort study","volume":"28","author":"Bitar","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.hroo.2025.06.016_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1751-7133.2011.00263.x","article-title":"Adherence to evidence-based guidelines for heart failure in physicians and their patients: lessons from the Heart Failure Adherence Retention Trial (HART)","volume":"18","author":"Calvin","year":"2012","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.hroo.2025.06.016_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086596","article-title":"Survey of Guideline Adherence for Treatment of Systolic Heart Failure in Real World (SUGAR): a multicenter, retrospective, observational study","volume":"9","author":"Yoo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.hroo.2025.06.016_bib30","article-title":"Adherence to the European Society of Cardiology guidelines for the treatment of chronic heart failure","author":"Sitepu","year":"2018","journal-title":"IOP Conference Series: Earth Environmental Science"},{"key":"10.1016\/j.hroo.2025.06.016_bib31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5430\/jha.v3n2p32","article-title":"Physician-adherence to pharmacotherapy guidelines for chronic heart failure in a tertiary health facility in Lagos, Nigeria","volume":"3","author":"Ajuluchukwu","year":"2014","journal-title":"J Hosp Admin"},{"key":"10.1016\/j.hroo.2025.06.016_bib32","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.3346\/jkms.2021.36.e252","article-title":"Evaluation of adherence to guideline for heart failure with reduced ejection fraction in heart failure with preserved ejection fraction and with or without atrial fibrillation","volume":"36","author":"Ahn","year":"2021","journal-title":"J Korean Med Sci"},{"year":"2017","series-title":"Goldilocks Dilemma of Dose Titration in Heart Failure With Reduced Ejection Fraction: Too Little, Too Much, or Just Right?","author":"Allen","key":"10.1016\/j.hroo.2025.06.016_bib33"},{"key":"10.1016\/j.hroo.2025.06.016_bib34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/VHRM.S131259","article-title":"The changing trend of cardiovascular disease and its clinical characteristics in Ethiopia: hospital-based observational study","volume":"13","author":"Tefera","year":"2017","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.hroo.2025.06.016_bib35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ahj.2016.10.012","article-title":"Beta-blocker dosage and outcomes after acute coronary syndrome","volume":"184","author":"Allen","year":"2017","journal-title":"Am Heart J"},{"key":"10.1016\/j.hroo.2025.06.016_bib36","article-title":"Assessment of physician adherence to guideline recommended medication in heart failure with REDUCED ejection fraction at outpatient cardiac clinic; retrospective cross sectional study at black lion specialized hospital","volume":"60","author":"Temesgen","year":"2022","journal-title":"Ethiop Med J"},{"key":"10.1016\/j.hroo.2025.06.016_bib37","first-page":"657","article-title":"Adherence to the guidelines on the management of systolic heart failure in ambulatory care in Poland. Data from the international QUALIFY survey","volume":"127","author":"Opolski","year":"2017","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.hroo.2025.06.016_bib38","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/ejhf.887","article-title":"Physicians\u2019 guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry","volume":"19","author":"Komajda","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hroo.2025.06.016_bib39","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ejhf.510","article-title":"Physicians\u2019 adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey","volume":"18","author":"Komajda","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hroo.2025.06.016_bib40","doi-asserted-by":"crossref","first-page":"130","DOI":"10.15420\/cfr.2017:13:1","article-title":"Quality of physician adherence to guideline recommendations for life-saving treatment in heart failure: an international survey","volume":"3","author":"Cowie","year":"2017","journal-title":"Card Fail Rev"},{"key":"10.1016\/j.hroo.2025.06.016_bib41","doi-asserted-by":"crossref","unstructured":"McGinlay M, Straw S, Byrom-Goulthorp R, et al. Suboptimal dosing of \u03b2-blockers in chronic heart failure: a missed opportunity? 2022;37:589\u2013594.","DOI":"10.1097\/JCN.0000000000000847"},{"key":"10.1016\/j.hroo.2025.06.016_bib42","first-page":"1","article-title":"Treatment optimization of angiotensin-converting enzyme inhibitors and associated factors in ayder comprehensive specialized hospital: a cross-sectional","volume":"11","author":"Atey","year":"2018","journal-title":"study"},{"key":"10.1016\/j.hroo.2025.06.016_bib43","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3904\/kjim.2023.223","article-title":"Optimization of guideline-directed medical treatment for heart failure patients with reduced ejection fraction","volume":"38","author":"Bak","year":"2023","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.hroo.2025.06.016_bib44","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.jacc.2022.03.351","article-title":"Underutilization of guideline-directed medical therapy in heart failure: can digital health technologies PROMPT change?","volume":"79","author":"Van Spall","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2025.06.016_bib45","article-title":"Physicians\u2019adherence to Guideline-Directed Medical Therapy for Heart Failure and Patients\u2019 outcomes in a Kenyan Referral Hospital","author":"Mucyo","year":"2023","journal-title":"MedRxiv"},{"key":"10.1016\/j.hroo.2025.06.016_bib46","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4103\/0256-4947.51794","article-title":"Optimal dosing of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: a cross-sectional study in Palestine","volume":"29","author":"Sweileh","year":"2009","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.hroo.2025.06.016_bib47","first-page":"481","article-title":"Angiotensin-converting enzyme inhibitor dose optimization and its associated factors at Felege Hiwot comprehensive specialized hospital, Bahir Dar, Ethiopia","author":"Gelaye","year":"2022","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.hroo.2025.06.016_bib48","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1365-2710.2001.00364.x","article-title":"Evaluation of the use of evidence-based angiotensin-converting enzyme inhibitor criteria for the treatment of congestive heart failure: opportunities for pharmacists to improve patient outcomes","volume":"26","author":"Pearson","year":"2001","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.hroo.2025.06.016_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72836-4","article-title":"Treatment optimization of beta-blockers in chronic heart failure therapy","volume":"10","author":"Niriayo","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.hroo.2025.06.016_bib50","doi-asserted-by":"crossref","first-page":"e491","DOI":"10.1016\/j.ijcard.2014.01.002","article-title":"Assessment of guideline adherence in hospitalized heart failure patients with systolic dysfunction in Dubai, United Arab Emirates","volume":"172","author":"Sharif-Askari","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hroo.2025.06.016_bib51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3126\/njh.v17i1.28804","article-title":"Adherence to guideline-directed medical therapy among left ventricular systolic dysfunction patients in Shahid Gangalal National Heart Centre, Kathmandu, Nepal","volume":"17","author":"Manandhar","year":"2020","journal-title":"Nepalese Heart J"},{"key":"10.1016\/j.hroo.2025.06.016_bib52","article-title":"The utilization of spironolactone in heart failure patients at a tertiary Hospital in Saudi Arabia","volume":"12","author":"Alotaibi","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.hroo.2025.06.016_bib53","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006540","article-title":"Use of mineralocorticoid receptor antagonists in patients with heart failure and comorbid diabetes mellitus or chronic kidney disease","volume":"6","author":"Cooper","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hroo.2025.06.016_bib54","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-030514","article-title":"Guideline-directed medical therapy in elderly patients with heart failure with reduced ejection fraction: a cohort study","volume":"10","author":"Seo","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.hroo.2025.06.016_bib55","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s40266-019-00733-1","article-title":"Clinical pharmacy services in older inpatients: an evidence-based review","volume":"37","author":"Van der Linden","year":"2020","journal-title":"Drugs Aging"},{"key":"10.1016\/j.hroo.2025.06.016_bib56","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/eurheartj\/ehn539","article-title":"Contemporary management of octogenarians hospitalized for heart failure in Europe: euro Heart Failure Survey II","volume":"30","author":"Komajda","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2025.06.016_bib57","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/heartjnl-2019-315240","article-title":"Guideline-directed therapy at discharge in patients with heart failure and atrial fibrillation","volume":"106","author":"Ahn","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.hroo.2025.06.016_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12872-021-01868-z","article-title":"Evaluation of the prescribing practice of guideline-directed medical therapy among ambulatory chronic heart failure patients","volume":"21","author":"Parajuli","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.hroo.2025.06.016_bib59","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/eurjhf\/hfp142","article-title":"Adherence to medication according to sex and age in the CHARM program","volume":"11","author":"Granger","year":"2009","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10.1016\/j.hroo.2025.06.016_bib60","first-page":"S212","article-title":"Evaluation of the treatment gap between clinical guidelines and the utilization of renin-angiotensin-aldosterone system inhibitors","volume":"21","author":"Epstein","year":"2015","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.hroo.2025.06.016_bib61","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1161\/01.CIR.94.11.2807","article-title":"Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure","volume":"94","author":"Bristow","year":"1996","journal-title":"Circulation"}],"container-title":["Heart Rhythm O2"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666501825002351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666501825002351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T21:48:08Z","timestamp":1762638488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666501825002351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":61,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2666501825002351"],"URL":"https:\/\/doi.org\/10.1016\/j.hroo.2025.06.016","relation":{},"ISSN":["2666-5018"],"issn-type":[{"type":"print","value":"2666-5018"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of physicians\u2019 adherence to guideline-directed medical therapy among patients with heart failure with reduced ejection fraction at the University of Gondar Comprehensive Specialized Hospital, Northwest, Ethiopia, 2023","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm O2","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hroo.2025.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Heart Rhythm Society. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}